Argpessin
Vasopressin analog with potent vasoconstrictive and antidiuretic activity. Essential peptide for critical care hemodynamic support and diabetes insipidus management.
Argpessin (Linaclotide) is a 14-amino acid synthetic peptide and a first-in-class guanylate cyclase-C (GC-C) receptor agonist. It is structurally related to the endogenous guanylin peptide family and acts locally in the gut to treat gastrointestinal disorders. The peptide contains three disulfide bridges that confer structural stability and biological activity.
| Parameter | Specification |
| CAS | 851199-59-2 |
| Category | Cardiovascular |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Vasodilatory shock, diabetes insipidus, hemostasis, critical care |
| CAS | 851199-59-2 |
|---|---|
| Applications | Esophageal Variceal Bleeding, Guanylate Cyclase-C (GC-C) Agonist, IBS-C |
Related products
-
Setmelanotide
CAS: 920014-72-8Applications: Appetite Regulation, Genetic Obesity, MC4R Agonist, metabolic syndrome -
Liraglutide
CAS: 204656-20-2Applications: cardiovascular risk reduction, GLP-1, obesity management -
Orforglipron
CAS: 2212020-52-3Applications: obesity management, Oral GLP-1 Development, Type 2 diabetes -
Survodutide
CAS: 2805997-46-8Applications: Liver Fat, NASH, obesity management, Type 2 diabetes